Ireland - English - HPRA (Health Products Regulatory Authority)

b. braun melsungen ag - isoleucine; leucine ; lysine hydrochloride; methionine; phenylalanine; threonine; tryptophan; valine; arginine monoglutamate ; alanine; aspartic acid; glutamic acid ; glycine; proline; serine; magnesium acetate tetrahydrate; sodium acetate trihydrate ; potassium dihydrogen phosphate; potassium hydroxide; sodium hydroxide ; glucose monohydrate; calcium chloride dihydrate; histidine hydrochloride monohydrate - solution for infusion - n/a - amino acids/carbohydrates/minerals/vitamins, combinations

Canada - English - Health Canada

centravet products - alanine; valine; dl-methionine; isoleucine; leucine; tyrosine; phenylalanine; histidine; lysine; arginine; tryptophan; calcium d-pantothenate; dextrose; calcium chloride; potassium chloride; magnesium sulfate; sodium acetate; sodium glutamate; riboflavin 5'-phosphate sodium; vitamin b12; pyridoxine hydrochloride; nicotinamide; thiamine hydrochloride; l-aspartic acid; threonine; serine; glutamic acid; proline; glycine - liquid - 10.5mg; 22.3mg; 9.1mg; 17.5mg; 28.5mg; 4.9mg; 15.2mg; 8.9mg; 25.8mg; 11.8mg; 3.8mg; 50mg; 50g; 150mg; 200mg; 200mg; 2.5g; 40mg; 40mg; 50mcg; 100mg; 1.5g; 100mg; 24.7mg; 14.4mg; 18.9mg; 66.6mg; 33.6mg; 6.7mg - alanine 10.5mg; valine 22.3mg; dl-methionine 9.1mg; isoleucine 17.5mg; leucine 28.5mg; tyrosine 4.9mg; phenylalanine 15.2mg; histidine 8.9mg; lysine 25.8mg; arginine 11.8mg; tryptophan 3.8mg; calcium d-pantothenate 50mg; dextrose 50g; calcium chloride 150mg; potassium chloride 200mg; magnesium sulfate 200mg; sodium acetate 2.5g; sodium glutamate 40mg; riboflavin 5'-phosphate sodium 40mg; vitamin b12 50mcg; pyridoxine hydrochloride 100mg; nicotinamide 1.5g; thiamine hydrochloride 100mg; l-aspartic acid 24.7mg; threonine 14.4mg; serine 18.9mg; glutamic acid 66.6mg; proline 33.6mg; glycine 6.7mg - amino acids/carbohydrates/minerals/vitamins, comb - horses

Canada - English - Health Canada

canat laboratories inc. - d-alpha tocopherol; ascorbic acid; thiamine hydrochloride; vitamin b2; nicotinic acid; vitamin b12; d-pantothenic acid (calcium d-pantothenate); folic acid; biotin; choline bitartrate; inositol; dl-methionine; calcium (calcium hvp chelate); phosphorus (phosphorus hvp chelate); magnesium (magnesium hvp chelate); iron (iron hvp chelate); zinc (zinc hvp chelate); manganese (manganese hvp chelate); copper (copper hvp chelate); selenium (selenium hvp chelate); chromium (chromic chloride, chromium hvp chelate); d-alpha tocopheryl acetate; ascorbic acid; retinol palmitate; vitamin d; iodine (kelp) - package - 50unit; 150mg; 52mg; 52mg; 52mg; 52mcg; 52mg; .2mg; 52mcg; 53mg; 52mg; 52mg; 125mg; 125mg; 50mg; 15mg; 10mg; 1mg; 1mg; 25mcg; 25mcg; 200unit; 500mg; 10000unit; 400unit; .1mg - d-alpha tocopherol 50unit; ascorbic acid 150mg; thiamine hydrochloride 52mg; vitamin b2 52mg; nicotinic acid 52mg; vitamin b12 52mcg; d-pantothenic acid (calcium d-pantothenate) 52mg; folic acid .2mg; biotin 52mcg; choline bitartrate 53mg; inositol 52mg; dl-methionine 52mg; calcium (calcium hvp chelate) 125mg; phosphorus (phosphorus hvp chelate) 125mg; magnesium (magnesium hvp chelate) 50mg; iron (iron hvp chelate) 15mg; zinc (zinc hvp chelate) 10mg; manganese (manganese hvp chelate) 1mg; copper (copper hvp chelate) 1mg; selenium (selenium hvp chelate) 25mcg; chromium (chromic chloride, chromium hvp chelate) 25mcg; d-alpha tocopheryl acetate 200unit; ascorbic acid 500mg; retinol palmitate 10000unit; vitamin d 400unit; iodine (kelp) .1mg - vitamins & minerals

Kenya - English - Pharmacy and Poisons Board

prisma pharma fze p.o.box 17269, 605, jafza view 18, jebel ali free - amino acids and vitamins granules - oral drops, granules for solution - each 5g contains: l-isoleucine100mg,l-leucine… - other nutrients: amino

Kenya - English - Pharmacy and Poisons Board

prisma pharma fze p.o.box 17269, 605, jafza view 18, jebel ali free - amino acids and vitamins liquid - oral liquid - each 5 ml contains: l-isoleucine usp 5 mg… - other nutrients: amino

Kenya - English - Pharmacy and Poisons Board

pt sanbe farma jl taman sari no.10 bandung indonesia - l-isoleucine l-leucine l-lysine l-maleate l… - infusion - each 500 ml contains:l-isoleucine 3.800 g… - other nutrients: amino

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

hankook korus pharm co. - dl-methionine, l-leucine, l-valine, l-isoleucine, l-threonine, l-tryptophan, l-phenylalanine, l-lysine (l-lysine hydrochloride), vitamin a, vitamin d2, vitamin e, vitamin b1, vitamin b2, vitamin b3, vitamin b6, calcium pantothenate, vitamin b12, folic acid, vitamin c - capsules - 9,2mg+ 9,15mg+ 5mg+ 5mg+ 5mg+ 5mg+ 5mg+ 25mg+ 1000iu+ 100iu+ 10mg+ 2,5mg+ 1,5mg+ 10mg+ 5mg+ 2.5mg+ 0,5mcg+ 100mcg+ 25mg

United States - English - NLM (National Library of Medicine)

cardinal health 107, llc - metoclopramide hydrochloride (unii: w1792a2rvd) (metoclopramide - unii:l4yeb44i46) - metoclopramide 5 mg in 1 ml - metoclopramide injection is indicated for the relief of symptoms associated with acute and recurrent diabetic gastric stasis. metoclopramide injection is indicated for the prophylaxis of vomiting associated with emetogenic cancer chemotherapy. metoclopramide injection is indicated for the prophylaxis of postoperative nausea and vomiting in those circumstances where nasogastric suction is undesirable. metoclopramide injection may be used to facilitate small bowel intubation in adults and pediatric patients in whom the tube does not pass the pylorus with conventional maneuvers. metoclopramide injection may be used to stimulate gastric emptying and intestinal transit of barium in cases where delayed emptying interferes with radiological examination of the stomach and/or small intestine. metoclopramide should not be used whenever stimulation of gastrointestinal motility might be dangerous, e.g., in the presence of gastrointestinal hemorrhage, mechanical obstruction, or perforation. metoclopramide is contraindicated in patients with pheochromocytoma because the drug may cause a hypertensive crisis, probably due to release of catecholamines from the tumor. such hypertensive crises may be controlled by phentolamine. metoclopramide is contraindicated in patients with known sensitivity or intolerance to the drug. metoclopramide should not be used in epileptics or patients receiving other drugs which are likely to cause extrapyramidal reactions, since the frequency and severity of seizures or extrapyramidal reactions may be increased.

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - metoclopramide hydrochloride (unii: w1792a2rvd) (metoclopramide - unii:l4yeb44i46) - metoclopramide 10 mg - metoclopramide tablets, usp are indicated for the: limitations of use: metoclopramide tablets, usp are not recommended for use in pediatric patients due to the risk of developing tardive dyskinesia (td) and other extrapyramidal symptoms as well as the risk of methemoglobinemia in neonates [see use in specific populations (8.4)]. metoclopramide tablets are contraindicated: risk summary published studies, including retrospective cohort studies, national registry studies, and meta-analyses, do not report an increased risk of adverse pregnancy-related outcomes with use of metoclopramide during pregnancy. there are potential risks to the neonate following exposure in utero to metoclopramide during delivery [see clinical considerations]. in animal reproduction studies, no adverse developmental effects were observed with oral administration of metoclopramide to pregnant rats and rabbits at exposures about 6 and 12 times the maximum recommended human dose (mrhd) [see data] . the estimated background risk of major b

United States - English - NLM (National Library of Medicine)

preferred pharmaceuticals, inc. - metoclopramide hydrochloride (unii: w1792a2rvd) (metoclopramide - unii:l4yeb44i46) - metoclopramide 10 mg - the use of metoclopramide  tablets, usp is recommended for adults only. therapy should not exceed 12 weeks in duration. symptomatic gastroesophageal reflux:  metoclopramide tablets, usp are indicated as short-term (4 to 12 weeks) therapy for adults with symptomatic, documented gastroesophageal reflux who fail to respond to conventional therapy. the principal effect of metoclopramide is on symptoms of postprandial and daytime heartburn with less observed effect on nocturnal symptoms. if symptoms are confined to particular situations, such as following the evening meal, use of metoclopramide as single doses prior to the provocative situation should be considered, rather than using the drug throughout the day. healing of esophageal ulcers and erosions has been endoscopically demonstrated at the end of a 12-week trial using doses of 15 mg q.i.d. as there is no documented correlation between symptoms and healing of esophageal lesions, patients with documented lesions should be monitored endoscopically. diabetic g